The original combo trial now shows completed with
Post# of 329
https://clinicaltrials.gov/ct2/history/NCT024...udyPageTop
Quote:
Subjects will be on existing ART for one week followed by PRO 140 700mg weekly SC Inj. + existing ART for the next week. Subsequently, all subjects will enter the 24-week single-arm, open-label treatment period. During this period, all subjects will receive PRO 140 SC injection and Optimized Background Therapy.